These post-mortem findings in combination with identification of the TERT promoter mutation allowed for a histomolecular diagnosis of glioblastoma, IDH-wildtype [5], completely in line with the diagnosis suggested by nanopore sequencing of CSF during the life of the patient. The gene discussed is TERT; the disease is glioblastoma.